» Articles » PMID: 31232669

Beyond Obesity: The Rising Incidence and Mortality Rates of Uterine Corpus Cancer

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2019 Jun 25
PMID 31232669
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Trends in gynaecologic cancer mortality and the impact of the COVID-19 pandemic in the United States.

Xi Y, Guo Y, Qiu S, Lv F, Deng Y, Xie J Infect Agent Cancer. 2024; 19(1):4.

PMID: 38378712 PMC: 10880335. DOI: 10.1186/s13027-024-00567-6.


In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries.

Ghosh D, Chowdhury R, Dutta R, Mukhopadhyay I, Mukhopadhyay A, Roychoudhury S Gynecol Oncol Rep. 2023; 47:101209.

PMID: 37293351 PMC: 10245003. DOI: 10.1016/j.gore.2023.101209.


Roles of N-methyladenosine (mA) modifications in gynecologic cancers: mechanisms and therapeutic targeting.

Chen J, Guo B, Liu X, Zhang J, Zhang J, Fang Y Exp Hematol Oncol. 2022; 11(1):98.

PMID: 36371254 PMC: 9652818. DOI: 10.1186/s40164-022-00357-z.


Annual report to the nation on the status of cancer, part 1: National cancer statistics.

Cronin K, Scott S, Firth A, Sung H, Henley S, Sherman R Cancer. 2022; 128(24):4251-4284.

PMID: 36301149 PMC: 10092838. DOI: 10.1002/cncr.34479.


Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis.

Hazelwood E, Sanderson E, Tan V, Ruth K, Frayling T, Dimou N BMC Med. 2022; 20(1):125.

PMID: 35436960 PMC: 9017004. DOI: 10.1186/s12916-022-02322-3.


References
1.
Clarke M, Devesa S, Harvey S, Wentzensen N . Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers. J Clin Oncol. 2019; 37(22):1895-1908. PMC: 6675596. DOI: 10.1200/JCO.19.00151. View

2.
Kramer M, Hogue C, Dunlop A, Menon R . Preconceptional stress and racial disparities in preterm birth: an overview. Acta Obstet Gynecol Scand. 2011; 90(12):1307-16. PMC: 5573146. DOI: 10.1111/j.1600-0412.2011.01136.x. View

3.
Walther-Antonio M, Chen J, Multinu F, Hokenstad A, Distad T, Cheek E . Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016; 8(1):122. PMC: 5123330. DOI: 10.1186/s13073-016-0368-y. View

4.
Toufexis D, Rivarola M, Lara H, Viau V . Stress and the reproductive axis. J Neuroendocrinol. 2014; 26(9):573-86. PMC: 4166402. DOI: 10.1111/jne.12179. View

5.
MacKay H, Levine D, Bae-Jump V, Bell D, McAlpine J, Santin A . Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget. 2017; 8(48):84579-84594. PMC: 5663622. DOI: 10.18632/oncotarget.19961. View